7Sultan SM,Begum S,Isenberg DA.Prevalence,patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematologic problems.Rheumatology(Oxford),2003,42(2):230-234.
8Cervera R,Khamashta MA,Font J,et al.Morbidity and mortality in systemic lupus erythematosus during 5 years follow-up.Medicine,1999,78(3):167-175.
5[1]Tom EM, Cohen As, Fries JF,et al.The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum,1982,25:1271
6[7]Gourley MF,Austin RA Ⅲ,Scott D, et al.Methylprednisolone and cyclophosphamide,alone or in combination,in patients with lupus nephritis:a randomized controlled trial.Ann Intern Med,1996,125:549
7[8]Fu LW,Yang LY,Chen WP,et al.Clinical efficacy of cyclosporin A neoral in the treatment of pediatric lupus nephritis with heavy proteinuria.Br J Rheum,1998,37:217
8Papadaki HA, Boumpas DT, Gibson FM, et al. Increased apoptosis of bone marrow CD34^+ cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. Br J Haematol, 2001,115:167-174.
9Sultan SM, Begum S, Isenberg DA. Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems. Rheumatology (Oxford), 2003,42:230-234.
10Kokori SI, Ioannidis JP, Voulgarelis M, et al. Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. Am J Med, 2000,108 : 198-204.
